Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 61,325 | 68,915 | 91,140 | 143,618 | 35,151 |
| Marketable Securities | 68,321 | 67,067 | 49,355 | 2,000 | 2,000 |
| Receivables | 52 | 124 | 219 | 168 | 336 |
| TOTAL | $130,986 | $137,481 | $141,208 | $146,371 | $38,250 |
| Non-Current Assets | |||||
| PPE Net | 55 | 57 | 64 | 65 | 68 |
| Other Non-Current Assets | 71 | 71 | 71 | 200 | 132 |
| TOTAL | $126 | $128 | $135 | $266 | $200 |
| Total Assets | $131,112 | $137,609 | $141,343 | $146,637 | $38,449 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,053 | 504 | 416 | 2,143 | 3,395 |
| Accrued Expenses | 8,504 | 3,074 | 2,324 | 1,769 | 3,439 |
| TOTAL | $10,557 | $3,578 | $2,739 | $3,912 | $6,834 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $10,557 | $3,578 | $2,739 | $3,912 | $6,834 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,928 | 29,397 | 29,387 | 29,228 | 29,223 |
| Common Shares | 3 | 3 | 3 | 3 | 2 |
| Retained earnings | -88,256 | -73,057 | -66,641 | -62,108 | -57,565 |
| Other shareholders' equity | -105 | -67 | -48 | 0 | 0 |
| TOTAL | $120,555 | $134,032 | $138,604 | $142,725 | $31,615 |
| Total Liabilities And Equity | $131,112 | $137,609 | $141,343 | $146,637 | $38,449 |